CEP-37440 | Interleukin Related interleukin-related.com

Product Name :
CEP-37440

Search keywords :
CEP-37440

drugId :
null

Target Vo:
Anaplastic lymphoma kinase

Target Vo Short Name :
ALK

Moa_Name:
Focal adhesion kinase 1 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Teva

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Solid tumours

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
HRP-conjugated AffiniPure Goat Anti-Mouse IgG H&L
CaMKII alpha Antibody
Phospho-Histone H2A.X (Ser139) Antibody: Phospho-Histone H2A.X (Ser139) Antibody is a non-conjugated and Mouse origined monoclonal antibody about 15 kDa, targeting to Histone H2AX. It can be used for WB,ICC/IF assays with N-6*His-tag, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts